Introduction {#Sec1}
============

In 1967, Ashbaugh and colleagues \[[@CR1]\] proposed a new syndrome in adults called acute respiratory distress syndrome (ARDS). Since then, many studies have investigated ARDS. In 2012, the Berlin ARDS definition \[[@CR2]\] was published and found that the greater the severity of ARDS was, the higher the mortality rate would be. To decrease the mortality rate of ARDS, researchers have attempted to improve and implement respiratory support strategies, including incorporating a small tidal volume \[[@CR3]\], high positive end-expiratory pressure (PEEP) \[[@CR4]\], prone position ventilation \[[@CR5]\], the lung recruitment manoeuvre \[[@CR6]\], the use of neuromuscular blockers \[[@CR7]\], high-frequency oscillatory ventilation (HFOV) \[[@CR8], [@CR9]\], and extracorporeal membrane oxygenation (ECMO) \[[@CR10]--[@CR12]\]. Some of the techniques have resulted in excellent progress while others were still with uncertain effect. However, there is limited information on the use of these strategies in the treatment of ARDS patients, and prospective studies from mainland China are especially lacking \[[@CR13], [@CR14]\].

We aimed to address some clinically important questions regarding ARDS epidemiology and management in mainland China. To date, very few studies \[[@CR14]\] have mentioned the incidence of ARDS in some regions of China, let alone the use of lung protective interventions and adjuncts. Providing insight into the use of these interventions could enable the development of more effective interventions in clinical practice.

Therefore, we undertook the CHARDS (China Acute Respiratory Distress Syndrome epidemiology) study to assess the medical/respiratory ICU epidemiology and respiratory support of ARDS and to understand how clinicians use mechanical ventilation and adjunctive interventions in routine clinical practice.

Methods {#Sec2}
=======

Study aim, design, and setting {#Sec3}
------------------------------

This was a multicentre, prospective longitudinal study. The aim of the study was to evaluate the incidence and mortality of ARDS in medical/respiratory intensive care units (MICUs/RICUs), to assess ventilation management and the use of adjunct therapy in routine clinical practice for patients fulfilling the Berlin definition of ARDS in mainland China. The study was approved by the institutional ethics committees of the participating centres. We conducted this trial in 18 ICUs in mainland China from March 2016 to February 2018. The study protocol was approved by the China-Japan Friendship Hospital ethics committee. Informed consent was obtained from all included patients. The funding source (CAMS Innovation Fund for Medical Sciences and Beijing Municipal Science and Technology Project) is an academic nonprofit organization that played no role in the study. We aimed to recruit a broadly representative sample of medical/respiratory ICUs in mainland China.

All patients met the ARDS Berlin definition for the first incidence of ARDS \[[@CR2]\] and were admitted from March 1, 2016, to February 28, 2018, to 18 MICUs. The exclusion criteria were age younger than 18 years; chronic respiratory failure due to chronic respiratory diseases, such as chronic obstructive pulmonary disease; bronchiectasis or lung fibrosis; or inability or unwillingness to provide informed consent.

Data collection and quality control {#Sec4}
-----------------------------------

Day 1 was defined as the first day that the ARDS criteria were met after ICU admission. The case report form prompted investigators to provide an expanded data set for days 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 21, and 28 or at ICU discharge, hospital discharge, or death. The acute physiology and chronic health evaluation (APACHE) II score and sequential organ failure assessment (SOFA) score were recorded using data from the first 24 h in the ICU. SOFA scores ≥ 3 referring to one organ were defined as failure of that organ. Fluid balance, including daily input and output, was recorded from day 1 until day 14. All data were recorded as close as possible to 8 AM each day. Patient outcomes included the date of ICU discharge and the date of hospital discharge.

Before data entry, all the site investigators were trained to fill in the case report form. During data entry, two supervisors checked the quality of the case report forms and provided feedback to the investigators. In addition, prior to analysis, all data were screened for potentially erroneous data and outliers. These data were verified or corrected by the site investigators.

Identification and recognition of ARDS {#Sec5}
--------------------------------------

The diagnosis of ARDS was made by clinicians according to the Berlin ARDS definition \[[@CR2]\] as follows: (1) the presence of acute hypoxaemic respiratory failure; (2) onset within 1 week of insult or the presence of new (within 7 days) or worsening respiratory symptoms; (3) bilateral opacities on chest X-ray or computed tomography not fully explained by effusions, lobar or lung collapse, or nodules; and (4) cardiac failure that was not the primary cause of acute hypoxaemic respiratory failure. All ICU patients were screened daily for ARDS. The patients who had acute hypoxaemia with PaO~2~/FIO~2~ (P/F) ≤ 300 mmHg were screened for ARDS. Chest X-ray or chest tomography was performed when P/F ≤ 300 mmHg (chest X-ray or chest tomography performed before the day of screening was also allowable), and the patients were managed with noninvasive or invasive ventilation with PEEP or CPAP≥ 5 cmH2O. The arterial blood gas analysis was repeated 15 min after ventilation and confirmed the P/F. The investigators then diagnosed the ARDS when the patients met the above criteria and signed consent forms, and subsequently, the investigators completed the case report forms.

ARDS severity and mechanical ventilation parameters {#Sec6}
---------------------------------------------------

Patients with ARDS undergoing noninvasive or invasive ventilation were categorized on the day of ARDS diagnosis based on their PaO~2~/FIO~2~ ratios into mild (200 \< PaO~2~/FIO~2~ ≤ 300 mmHg), moderate (100 \< PaO~2~/FIO~2~ ≤ 200 mmHg), and severe (PaO~2~/FIO~2~ ≤ 100 mmHg) according to the Berlin definition \[[@CR2]\]. Moderate or severe ARDS patients who underwent noninvasive ventilation were also included in our study due to a lack of clarity in the Berlin definition. The end-inspiratory plateau pressure was measured during the first 24 h after invasive ventilation. This value was determined by application of an end-inspiratory pause of sufficient time (at least 3.0 s) to ensure airway pressure equilibrium. The investigators were encouraged to use sedatives or neuromuscular blockers to eliminate spontaneous breathing. Invasive ventilator-free days were calculated as the number of days from weaning from invasive ventilation to day 28. Patients who died before weaning were considered to have a ventilator-free-day value of 0.

General management {#Sec7}
------------------

The clinician decided the methods of ventilation, noninvasive positive pressure ventilation (NPPV) or invasive positive pressure ventilation (IPPV). It was recommended that all ARDS patients be ventilated with a tidal volume of 5--8 ml/kg predicted body weight, a plateau pressure less than 30 cmH~2~O, and with PEEP and FIO~2~ combinations to maintain PaO~2~ above 55 mmHg or SpO~2~ above 88% before this study.

Outcome measures and statistical analysis {#Sec8}
-----------------------------------------

The primary goal of this study was the MICU/RICU incidence of ARDS in mainland China. Secondary outcomes included the ventilatory management of ARDS, the use of adjunctive interventions in routine clinical practice, and the ICU and hospital mortality of patients with ARDS.

Descriptive statistics included proportions for categorical variables and the mean (standard deviation) or median (interquartile range \[IQR\]) for continuous variables. No assumptions were made for missing data. For each parameter for which data points were missing, the value was omitted, and the denominator was adjusted accordingly. Data were unadjusted unless specifically stated otherwise. Proportions were compared using the *χ*^2^ or Fisher's exact tests, and continuous variables were compared using the *t* test or Wilcoxon rank sum test, as appropriate. A two-sided *p* value no greater than 0.05 was considered statistically significant. Logistic regression models were used to determine the effect of prognostic factors on hospital death by means of stepwise backward elimination procedures, after adjusting for covariates of which the *p* values were less than 0.05. Statistical analyses were conducted using SAS software, version 9.4 (SAS Institute Inc.), unless otherwise indicated.

Results {#Sec9}
=======

Participating ICUs and enrolled patients {#Sec10}
----------------------------------------

All participating centres were closed ICUs in tertiary teaching hospitals in metropolitan cities managed by full-time ICU doctors (see eAppendix 1 and eTable [1](#MOESM6){ref-type="media"}). Eighteen ICUs from 17 hospitals in different areas of mainland China were included (see Fig. [2](#Fig2){ref-type="fig"}). Of the 18,793 patients admitted to these ICUs during the enrolment period, 672 patients were diagnosed with ARDS according to the Berlin definition and 527 were analysed (Fig. [1](#Fig1){ref-type="fig"}). Table [1](#Tab1){ref-type="table"} outlines their main characteristics. In total, 527 patients were included in this study. The mean age was 55.2 ± 17.4 years, and 70% were males. The mean APACHE II and SOFA scores were 17.2 ± 7.8 and 7.4 ± 3.8, respectively. Most of the patients were from the emergency room or other wards, and the medical expenses were covered by medical insurance or rural cooperative medical care (eTable [2](#MOESM7){ref-type="media"}). Fig. 1Flow of patient screening and enrollmentTable 1Characteristics of patients with acute respiratory distress syndrome**ParameterARDSMildModerateSevere*P*** **value**^**a**^***n*** **= 527*n*** **= 51*n*** **= 250*n*** **= 226**APACHEII17.2 ± 7.815.8 ± 8.616.1 ± 7.418.8 ± 7.80.000SOFA7.4 ± 3.86.4 ± 3.86.8 ± 3.78.2 ± 3.90.000Age, mean, years55.2 ± 17.452.7 ± 17.854.2 ± 17.657.0 ± 17.00.065Men, no. (%)369 (70.0)26 (51.0)185 (74.0)158 (69.9)0.005BMI24.2 ± 4.623.6 ± 5.124.3 ± 4.624.2 ± 4.40.282Obesity, no. (%)65 (12.4)4 (8.0)29 (11.7)32 (14.2)0.4297Chronic lung diseases30 (5.7)0 (0.0)15 (6.0)15 (6.7)0.151Hypertension176 (33.6)12 (23.5)79 (31.6)85 (38.1)0.090Diabetes101 (19.3)8 (15.7)56 (22.4)37 (16.7)0.228Coronary diseases57 (10.9)0 (0.0)25 (10.0)32 (14.3)0.010Chronic cardiac failure26 (5.0)2 (3.9)14 (5.6)10 (4.5)0.806Cerebral vascular diseases52 (9.9)1 (2.0)32 (12.8)19 (8.5)0.040Chronic renal failure56 (10.7)5 (9.8)22 (8.8)29 (13.1)0.315Liver cirrhosis21 (4.0)1 (2.0)14 (5.6)6 (2.7)0204Connective tissue diseases35 (6.7)1 (2.0)20 (8.0)14 (6.3)0.275Active neoplasm41 (7.8)5 (9.8)16 (6.4)20 (9.0)0.500Alcohol use disorder21 (4.0)2 (3.9)15 (6.0)4 (1.8)0.051Smoking180 (34.4)15 (29.4)90 (36.0)75 (33.6)0.636*APACHE* acute physiology and chronic health evaluation, *SOFA* sequential organ failure assessment, *BMI* body weight index^a^*P* value represents comparisons across the ARDS severity categories for each variable

ICU incidence of ARDS {#Sec11}
---------------------

In total, 672 fulfilled the ARDS criteria during their ICU stays. ARDS represented 3.57% of total ICU admissions, but there were large variations between different ICUs (see Fig. [2](#Fig2){ref-type="fig"}). Among the 527 ARDS patients included in the final analysis, the prevalence rates of mild, moderate, and severe ARDS were 9.7% (51/527), 47.4% (250/527), and 42.9% (226/527), respectively. 91.7 (483/527) ARDS patients were diagnosed within 24 h of ICU admission (see eFig [4](#MOESM4){ref-type="media"}). The main risk factors for ARDS were pneumonia, extrapulmonary sepsis, pancreatitis, and aspiration (77%, 7.3%, 3.4%, and 3.3%, respectively) (see Table [2](#Tab2){ref-type="table"}). The patients' laboratory findings are listed in eTable [3](#MOESM8){ref-type="media"} in the supplement. Fig. 2Incidences of ARDS in different ICUs. The incidences of ARDS varied among different ICUs, with the highest incidence of 16.7% in China-Japan Friendship Hospital and the lowest incidence of 1.0% in the First Affiliated Hospital of Anhui Medical UniversityTable 2Risk factors for acute respiratory distress syndrome**ParameterARDSMildModerateSevere*n*** **= 527*n*** **= 51*n*** **= 250*n*** **= 226**Risk factors for ARDS Intrapulmonary441 (83.7)37 (72.5)207 (82.8)197 (87.2)  Pneumonia402 (77.0)32 (64.0)183 (73.5)187 (83.9)  Aspiration17 (3.3)1 (2.0)11 (4.4)5 (2.2)  Drowning3 (0.6)0 (0.0)3 (1.2)0 (0.0)  Pulmonary contusion10 (1.9)3 (6.0)6 (2.4)1 (0.4)  Others9 (1.7)1 (2.0)4 (1.6)4 (1.8) Extrapulmonary86 (16.3)14 (27.5)43 (17.2)29 (12.8)  Trauma8 (1.5)0 (0.0)7 (2.8)1 (0.4)  Extra pulmonary sepsis38 (7.3)7 (14.0)18 (7.2)13 (5.8)  Pancreatitis18 (3.4)5 (10.0)9 (3.6)4 (1.8)  Non-cardiogenic shock1 (0.2)0 (0.0)1 (0.4)0 (0.0)  Blood transfusion2 (0.4)1 (2.0)1 (0.4)0 (0.0)  Others23 (4.4)1 (2.0)10 (4.0)12 (5.4)*ARDS* acute respiratory distress syndrome

Mechanical ventilation management in patients with ARDS {#Sec12}
-------------------------------------------------------

A total of 228 ARDS patients initially received NPPV, among which 85 patients received NPPV for the diagnosis of ARDS. After diagnosis, these patients were switched to HFNC. Among the remaining 143 NPPV patients, the most popular mode was bilevel positive airway pressure (BiPAP), used for 114 (83.8%) patients, with an inspiratory positive airway pressure of 13.5 (12.0--15.0) and an expiratory positive airway pressure of 5.0 (5.0--7.0). In total, 65 of the 143 patients (45.5%) who received NPPV required invasive ventilation afterwards (see eTable [4](#MOESM9){ref-type="media"}).

In total, 299 (56.7%) ARDS patients initially received IPPV. Ventilator management varied with ARDS severity, and the ventilation modes on the first day of ARDS are shown in Table [3](#Tab3){ref-type="table"}. Pressure control was the most selected mode, used for 192 (48%) patients. The ARDS patients who received IPPV had a median tidal volume (VT) of 6.8 (5.8--7.9) ml/kg of predicted body weight and a median PEEP of 8 (6--12) cmH~2~O on the first day of IPPV. A total of 78.25% (313/400) of patients received a tidal volume of ≤ 8 ml/kg of PBW. PEEP was relatively low overall but became progressively higher in more severe patients. The plateau pressure and driving pressure on the first day of IPPV was 20 (16--26) cmH~2~O and 12 (8--16) cmH~2~O, respectively. Finally, 400 (75.9%) of all ARDS patients required invasive mechanical ventilation, which accounted for 18.5% (400/2168) of all ventilated patients in the same period. Table 3Characteristics of ARDS patients treated with invasive ventilation and use of adjunctive by severity category**ParameterARDSMildModerateSevere*P*** **value**^**b**^***n*** **= 527*n*** **= 51*n*** **= 250*n*** **= 226**D1 IPPV299 (56.7)25 (49.0)125 (50.0)149 (65.9)0.001IPPV during ICU400 (75.9)30 (58.8)177 (70.8)193 (85.4)0.000Mode on 1st day of IPPV Volume control ventilation55 (13.8)3 (10.0)22 (12.4)30 (13.8) Pressure control ventilation192 (48.0)11 (36.7)81 (45.8)100 (51.8) SIMV+PS47 (11.8)4 (13.3)18 (10.2)25 (13.0) Pressure support ventilation70 (17.5)7 (23.3)36 (20.3)27 (14.0) Bilevel32 (8.0)5 (16.7)18 (10.2)9 (4.7) Other modes4 (1.0)0 (0.0)2 (1.1)2 (1.0)PEEP median (IQR), cmH~2~O8 (6--12)7 (5--8)8 (6--10)10 (6--12)0.000*V*~T~, median (IQR) (ml/kg PBW)6.8 (5.8--7.9)7.0 (6.6--7.7)6.8 (5.9--8.0)6.8 (5.8--7.9)0.538Plateau pressure, median (IQR), cmH~2~O20 (16--26)20 (15--23)20 (15--25)22 (18--27)0.220Driving pressure^a^, median (IQR), cmH~2~O12 (8--16)14 (10--15)13 (8--16)12 (8--17)0.779Airway resistance^a^, median (IQR) cmH~2~O/L/S12.0 (8.0--18.2)12.0 (9.7--17.0)11.0 (7.8--19.0)12.0 (8.0--18.0)0.571Compliance^a^, median (IQR) ml/cmH~2~O35.0 (25.0--43.7)36.4 (30.7--43.0)36.4 (24.0--52.0)32.0 (25.0--42.0)0.191ABG, D1 ARDS PaO~2~/FIO~2~, median (IQR), mmHg113 (80--161)227 (206--270)142 (115--166)78 (59--96)0.000 PaCO~2~, median (IQR), mmHg36.3 (31.2--42.7)36.2 (29.6--39.0)35.9 (31.0--41.5)37.2 (31.8--45.2)0.044 pH, median (IQR)7.42 (7.36--7.46)7.43 (7.36--7.48)7.2 (7.36--7.46)7.41 (7.40--7.46)0.651 NMBAs107 (26.8)5 (16.7)43 (24.3)59 (30.6)0.177 RM61 (15.3)2 (6.7)26 (14.7)33 (17.1)0.322 PPV85 (21.3)3 (10.0)29 (16.4)53 (27.5)0.011 ECMO61 (15.3)2 (6.7)23 (13.0)36 (18.7)0.142 HFOV3 (0.8)0 (0.0)1 (0.6)2 (1.0)1.000 High-dose corticosteroid^c^157 (29.8)13 (25.5)59 (23.6)85 (37.6)0.003*IPPV* invasive positive pressure ventilation, *ICU* intensive care unit, *SIMV* synchronized intermittent mandatory ventilation, *PS* pressure support, *PEEP* positive end-expiratory pressure, *VT* tidal volume, *PBW* predicted body weight, *ABG* arterial blood gas, *NMBAs* neuromuscular blockade, *RM* lung recruitment manoeuvre, *PPV* prone position ventilation, *EMCO* extracorporeal membrane oxygenation, *HFOV* high-frequency oscillatory ventilation^a^Plateau pressure values, driving pressure values, airway resistance values, and respiratory compliance values are limited to patients in whom this value was reported. The number of measured patients is 211 cases. Patients receiving HFOV or ECMO were also excluded^b^*P* value represents comparisons across the ARDS severity categories for each variable^c^High-dose corticosteroids was defined as doses that were equal to or greater than the equivalent of 1 mg/kg of prednisolone

Use of adjunctive measures {#Sec13}
--------------------------

The use of adjunctive treatments in patients with ARDS is showed in Table [3](#Tab3){ref-type="table"}. Neuromuscular blockade was used in 107/400 (26.8%) ventilated patients, and recruitment manoeuvres (RMs) were used in 61/400 (15.3%) ventilated patients. Prone position was used in 85/400 (21.3%) ventilated patients and increased with the severity of ARDS, in 343 ventilated patients whose PFR ≤ 150 mmHg within 1 week of ARDS, only 24.8% (85) used prone position. None of the patients received nitric oxide as an adjunctive treatment. Three of the participating centres used extracorporeal membrane oxygenation. HFOV and ECMO were used in 3/400 (0.8%) and 61/400 (15.3%) invasively ventilated ARDS patients, respectively. High-dose steroids (which were defined as doses that were equal to or greater than the equivalent of 1 mg/kg of prednisolone) were used in 160 (30.4%) ARDS patients. There was a trend in which the higher the ARDS severity was, the more positive the fluid balance would be, especially for the first 4 days after ARDS diagnosis (see eTable [5](#MOESM10){ref-type="media"} in the supplement).

ARDS outcomes {#Sec14}
-------------

The severity of ARDS worsened in 154/301 (51.2%) patients with mild or moderate ARDS (Table [4](#Tab4){ref-type="table"}). Overall, the unadjusted numbers of ICU and hospital deaths from ARDS were 232/527 (44%) and 244/527 (46.3%), respectively. The hospital mortality in mild, moderate, and severe group were 31.4%, 40.4%, and 56.2%, respectively (see Table [4](#Tab4){ref-type="table"}). Survival curve showed a lower likelihood of survival in severe group compared with mild and moderate groups on day 1 (see Fig. [3](#Fig3){ref-type="fig"}). In total, life-sustaining care was withdrawn from 92/527 (17.5%) patients, and all of these patients died soon after withdrawal. The incidence of IPPV barotrauma was 7.8% (31/400), among which pneumothorax occurred in 23(4.3%) patients. Patients with a driving pressure of more than 15 cmH~2~O on the first day of IPPV had worse outcomes, but this was not the case for plateau pressure (eFigures [2](#MOESM2){ref-type="media"} and [3](#MOESM3){ref-type="media"}). Shock occurred in 191 (36.3%) patients. Hospital-acquired infections occurred in 135/527 (25.6%) patients, and most infections were hospital-acquired pneumonia (117/527, 22.3%). Extrapulmonary organ failure occurred in 241/527 (45.7%) ARDS patients. The univariate analysis of survival is showed in eTable [6](#MOESM11){ref-type="media"}. The multivariate model indicated that age \[hazard ratio (HR) 1.680; 95% CI 1.106--2.551; *p* = 0.015\], corticosteroid within 1 month \[HR 1.749, 95% CI 1.089--2.808, *p* = 0.021\], driving pressure \> 15 cmH~2~O \[HR 1.897, 95% CI 1.210--2.974, *p* = 0.005\], and shock \[HR 2.017, 95% CI 1.308--3.111, *p* = 0.002\] were independently significantly associated with hospital mortality. Table 4Outcomes of invasively ventilated patients by acute respiratory distress syndrome severity at diagnosis**ParameterARDSMildModerateSevere*P*** **value**^**a**^***n*** **= 527*n*** **= 51*n*** **= 250*n*** **= 226**Progression of ARDS severity Progression to moderate26/51 (51.0)26/51 (51.0)---- Progression to severe128/301 (42.5)16/51 (31.4)112/250 (44.8)--Invasive ventilation-free days to day 28, median (IQR), days6 (0--22)21 (0--28)12 (0--23)0 (0--18)0.000IPPV barotrauma31 (7.8)1 (3.3)15 (8.5)15 (7.7)0.5621 Subcutaneous emphysema14 (2.6)0 (0.0)7 (2.8)7 (3.0)0.2362 Mediastinal emphysema19 (3.6)0 (0.0)8 (3.2)11 (4.8)0.0946 Pneumothorax23 (4.3)1 (2.0)11 (4.4)11 (4.8)0.6149HAI135 (25.6)9 (17.6)58 (23.2)68 (30.1)0.089HAP117 (22.3)6 (12.0)50 (20.0)61 (27.2)0.031CRBSI23 (4.4)2 (4.0)9 (3.6)12 (5.4)0.640BSI31 (5.9)3 (5.9)12 (4.8)16 (7.1)0.5889Intra-abdominal infection10 (1.9)1 (2.0)5 (2.0)4 (1.8)0.983Other HAI15 (3.0)1 (2.0)8 (3.3)6 (2.8)0.879Organ failure At least one extrapulmonary organ failure241 (45.7)15 (29.4)104 (41.6)122 (54.0)0.001 Shock191 (36.3)14 (27.5)84 (33.2)94 (41.8)0.058 Kidney130 (24.7)5 (9.8)61 (24.4)64 (28.4)0.020  CRRT119 (22.6)10 (19.6)54 (21.6)55 (24.3)0.568 Liver57 (10.8)5 (9.8)22 (8.8)30 (13.3)0.275 Coagulation64 (12.2)5 (9.8)31 (12.4)28 (12.4)0.863 GCS38 (7.3)4 (7.8)14 (5.6)20 (9.0)0.378ICU length of stay, median (IQR), days11 (7, 21)7 (5, 17)12 (7, 20)12 (6, 21)0.080ICU mortality^c^232 (44.0)15 (29.4)96 (38.4)121 (53.5)0.000Hospital length of stay, median (IQR), days19 (10, 29)15 (9, 23)20 (12, 30)17 (9, 29)0.049Hospital mortality^c^244 (46.3)16 (31.4)101 (40.4)127 (56.2)0.000Withdrawal of life sustaining care^b^92 (17.5)5 (9.8)38 (15.2)49 (21.7)0.021Patients except withdrawal ICU mortality140 (32.2)10 (21.7)58 (27.4)72 (40.7)0.005 Hospital mortality152 (34.9)11 (23.9)63 (29.7)78 (44.1)0.003*ARDS* acute respiratory distress syndrome, *IPPV* invasive positive pressure ventilation, *HAI* hospital-acquired infection, *HAP* hospital-acquired pneumonia, *CRBSI* catheter-related blood stream infection, *BSI* blood stream infection, *CRRT* continuous renal replacement therapy, *GCS* Glasgow coma scale, *ICU* intensive care unit; organ failure: SOFA scores ≥ 3 referring to one organ were defined as failure of that organ^a^*P* value represents comparisons across the ARDS severity categories for each variable^b^All the withdrawal of life sustaining care patients discharged from the hospital were confirmed dead on the day of withdrawal^c^When ICU and hospital mortality were calculated, the withdrawal patients were includedFig. 3Probability of hospital survival by ARDS severity. Survival curve showed a lower likelihood of survival in severe group compared with mild and moderate groups on day 1

Discussion {#Sec15}
==========

In this prospective registry study carried out in 18 ICUs in mainland China, ARDS was still an important public health problem, with a low ICU incidence, geographic variation, and high hospital mortality. The low use of recommended adjuncts and the high ratio of withdrawal of life-sustaining care, among moderate to severe ARDS patients, were also found.

In this study, the average ARDS incidence was low in the MICUs/RICUs of mainland China, and there was nearly 17-fold variation in the incidences of different ICUs. Prior epidemiological studies reported an ARDS incidence ranging from 2 to 25% of ICU patients \[[@CR15]--[@CR18]\]. In the LUNGSAFE study \[[@CR15]\], which included ICUs from 50 countries, the geographic variation was also high, and the incidence in Asia was lower. In contrast to other studies, our study showed a lower ratio of mild ARDS and a higher ratio of moderate ARDS relative to severe ARDS, while in the LUNGSAFE study \[[@CR15]\], the proportions of mild, moderate, and severe ARDS were 30%, 46.6%, and 23.4%, respectively. The data included in the Berlin definition \[[@CR19]\] also showed proportions of 22%, 64%, and 14% for mild, moderate, and severe ARDS, respectively. The reason for the relatively low incidence of ARDS and high variation incidence between different ICUs in this study is threefold. First, the patients admitted to the different ICUs had different kinds of diseases. The leading ICU received severe cases of pneumonia from all over the country and had the highest incidence of ARDS, while patients in the ICUs with lower incidences of ARDS were limited to patients with chronic respiratory diseases such as COPD or interstitial lung diseases. Second, in the LUNGSAFE study \[[@CR15]\], Bellani et al. found that ARDS was underdiagnosed, and clinician recognition of ARDS was the lowest in patients with mild ARDS (51.3%; 95% CI, 47.5--55.0%). As the severity of ARDS increased, the proportion of clinician recognition increased accordingly. In our study, some of the patients with mild ARDS may not be recognized by clinicians in general wards or emergency room and had no chance to be transferred to an ICU, which may be both the reason of low incidence of ARDS and low ratio of mild ARDS cases. Third, there were also other ICUs in most of the included hospitals, such as surgical, general, or emergency ICUs, and some of the ARDS patients (especially for extrapulmonary ARDS patients) have been admitted there. There was also the possibility that because the screening protocol was implemented by the investigators but not the computer algorithm, some ARDS cases may have been missed by investigators. Other explanations of the low incidence may be the use of different definitions of ARDS in other studies (AECC or Berlin definition) and the prospective or retrospective designs of the studies.

Since 2000, variable ventilation strategies have been proven to be effective according to ARDS mechanical ventilation guidelines, including small tidal volume, appropriate PEEP, limit plateau pressure, and prone position ventilation. Some other strategies are inconclusive and still need more investigation, including the use of neuromuscular blockers, RMs, and ECMO. In our study, these proven or recommended approaches to mechanical ventilation and adjunctive measures appeared to be underused. The implementation of low tidal volume ventilation was in the highest agreement with the guidelines. 78.25% of the patients in this study had a tidal volume of ≤ 8 ml/kg PBW recommended as the guideline, which indicates the wide adoption of implementing a small tidal volume strategy by Chinese doctors. The other two important parameters consistent with the low tidal volume are the limitation of plateau pressure and driving pressure, which guarantee the avoidance of barotrauma. We found from the multivariate regression analysis that patients with a driving pressure \> 15 cmH~2~O had worse outcomes, while this was not the case for plateau pressure. This was in accordance with Amato's study \[[@CR20]\], which motivates us to focus more on the limitation of driving pressure. Higher PEEP was used in patients with severe ARDS compared with those with mild or moderate ARDS, as reported in prior studies \[[@CR15]\], but concerns have been raised by the relatively low PEEP found in our study compared to the recommended PEEP in ARDSnet \[[@CR3]\] and other studies \[[@CR6]\]. Adjunctive measures were used infrequently for RM, prone positioning, and neuromuscular blockade. Among 343 ventilated patients with P/F \< 150 mmHg within 1 week, only 85 (24.8%) patients used PPV. However, recent studies \[[@CR21]--[@CR23]\] about RM have shown only improvement for oxygenation but no benefit for mortality. It is possible that the relatively low use of adjunctive measures reflects the uncertain effect of the treatment or the low compliance to the guidelines among clinicians. Additionally, expensive measurements such as ECMO were not widely applied in the included centres (only in 3 ICUs).

Our study showed high ICU and hospital mortality rates of patients with ARDS. In fact, the mortality rates of ARDS have remained at approximately 36--50% since the syndrome was first described \[[@CR6], [@CR15], [@CR17], [@CR24]--[@CR28]\]. The reason for the high mortality rate may be fourfold. First, there was a high incidence of withdrawal of life-sustaining care, which has seldom been reported before. When we excluded withdrawal patients, the hospital mortality rate was 34.9% (152/435). When we included withdrawal patients who died soon after withdrawal, the mortality rate was 46.3% (244/527). Suchyta et al. \[[@CR29]\] found that withdrawal was more likely for patients older than 55 years (21/51) than for those 55 years or younger (3/32; *p* \< 0.001). However, most of the families made such decisions due to economic reasons or based on Chinese traditions in our study. Second, there was relatively low compliance with some of the recommended guidelines. Third, the therapeutic levels varied in different regions of China. Finally, limitations in the facilities resulted in the loss of opportunities to receive further treatment, such as ECMO. We also found the hospital mortality was not different between mild and moderate group; the main reason may be that 42 in 51 mild ARDS patients progressed to moderate or severe group, and also the number of the included ARDS cases was too small to be statistically significant.

This study had a number of limitations. Although the included hospitals are general hospitals across Mainland China, most of the included ICUs are respiratory ICUs, and the risk factors may be constrained to intrapulmonary elements; therefore, the extra pulmonary element-induced ARDS patients may have been underrepresented. Additionally, the number of included ICUs was relatively small, which may have led to selection bias and could not represent the reality in mainland China, limiting the generalizability of our findings. As an epidemiological study, we could not obtain patient data from the enrolled ICUs, so it is possible that we missed some patients who met the inclusion criteria for ARDS in participating centres, especially for patients with mild ARDS. To ensure our data quality, we assigned two doctors to check the quality of the case report forms from different centres every 3 months. To standardize the inclusion procedure, we offered all the investigators web-based training and midterm conferences. Two important respiratory mechanical parameters, namely, plateau pressure and driving pressure, were reported in only 52.8% (211/400) of all IPPV patients with ARDS. The reason for so few patients undergoing this measure may be that most of them were ventilated with the spontaneous ventilation mode. Additionally, doctors did not recognize that plateau pressure and driving pressure were important parameters for ARDS patients and that refractory tachypnoea may also affect the measurement of plateau pressure and driving pressure.

Conclusions {#Sec16}
===========

Among included ICUs in Mainland China, the ARDS incidence was lower than those found in other studies. Most concerning is the high mortality and withdrawal rates of life sustaining care in patients with moderate to severe ARDS. The ARDS patients were undertreated and had a relatively low level of compliance with the guidelines. The findings indicate the potential for improvement in early recognition of mild ARDS outside the ICU and standardization of ventilation management of ARDS patients.
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**Additional file 1: eFig 1.** Probability of hospital survival by driving pressure. Patients with a driving pressure greater than 15 cmH~2~O on day 1 of mechanical ventilation after ARDS diagnosis had a higher mortality.**Additional file 2: eFig 2.** Probability of hospital survival by plateau pressure. Patients with a plateau pressure of greater than 30 cmH~2~O on day 1 of mechanical ventilation after ARDS diagnosis had mortality similar to that of patients with a plateau pressure of less than 30 cmH~2~O.**Additional file 3: eFig 3.** Logistic regression of hospital mortality.**Additional file 4: eFig 4.** Time-to-event analysis of the time course of ARDS onset.**Additional file 5.** Characteristics of chinese hospitals and ICUs including process of care and ICU delivery systems.**Additional file 6: eTable 1.** Characteristics of participating centers.**Additional file 7: eTable 2.** Resources and types of medical expenses of acute respiratory distress syndrome patients.**Additional file 8: eTable 3.** Laboratory findings of acute respiratory distress syndrome patients.**Additional file 9: eTable 4.** Characteristics of ARDS patients treated with noninvasive ventilation by severity category at diagnosis.**Additional file 10: eTable 5.** Fluid balance of acute respiratory distress syndrome patients.**Additional file 11: eTable 6.** Comparison of survivors versus non-survivors in patients with ARDS.

ARDS

:   Acute respiratory distress syndrome

PEEP

:   High positive end-expiratory pressure

HFOV

:   High-frequency oscillatory ventilation

ECMO

:   Extracorporeal membrane oxygenation

MICUs/RICUs

:   Medical/respiratory intensive care units

APACHE

:   The acute physiology and chronic health evaluation

SOFA

:   Sequential organ failure assessment

NPPV

:   Non-invasive positive pressure ventilation

IPPV

:   Invasive positive pressure ventilation
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